z-logo
open-access-imgOpen Access
Serum Ustekinumab Concentrations Are Associated With Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index
Author(s) -
Margaret Walshe,
Krzysztof Borowski,
Robert Battat,
David Hudesman,
Douglas C. Wolf,
Lauren Okada,
Anjali Jain,
Mark S. Silverberg
Publication year - 2021
Publication title -
crohn s and colitis 360
Language(s) - English
Resource type - Journals
ISSN - 2631-827X
DOI - 10.1093/crocol/otab032
Subject(s) - interquartile range , medicine , gastroenterology , quartile , crohn's disease , receiver operating characteristic , area under the curve , confidence interval , crohn disease , ustekinumab , surgery , disease , adalimumab

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom